JORGENSEN NATHAN D. (Chief Financial Officer) received a stock award from VOYAGER THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/10/2026ACC: 0001104659-26-012669
Officer· Chief Financial Officer
Since Feb 2026
+182.75K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
182.75K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+32.25K
Price / share
—
Trade value
—
% of position
26.0%
2/6/2026
123.83K→156.08K
Total
Net shares
+32.25K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/6/2026 | A · Award | +32.25K | — | — | 26.0% | 123.83K | 156.08K |
| Total | +32.25K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
150.50K shares
Shares
+150.50K
Strike price
3.68
Held after
150.50K
Exercisable
—
2/6/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock150.50K shares | 2/6/2026 | A · Award | +150.50K | 3.68 | — | 150.50K |